Nextremity Solutions to acquire Lakeland Technology
Nextremity Solutions

Nextremity Solutions to acquire Lakeland Technology

Purchase of contract manufacturer supports Nextremity’s core business of innovative production development and micro-commercialization.


Nextremity Solutions Inc. has entered into a  letter of intent to acquire substantially all of the assets of Lakeland Technology Inc.

Lakeland Technology is an ISO 13485 certified contract manufacturer with a focus on quality. Its engineering staff assists with design for manufacturability (DfM) and specializes in manufacturing implants, instruments, complex assemblies, prototypes, and custom surgical instruments.

Nextremity Solutions’ i3 Strategic Solutions strategy focuses the company’s efforts on product development and micro-commercialization of innovative technologies. Nextremity is committed to delivering Revenue Ready solutions that include effective packaging, delivery systems, marketing, and educational support while providing products with proven sales and clinical efficacy.

Ryan Schlotterback, CTO of Nextremity Solutions says, “Lakeland Technology is an excellent strategic fit for Nextremity Solutions and supports our core business of innovative product development and our micro-commercialization strategy. As we continue to develop Revenue Ready solutions, it’s even more important that we are able to participate in the entire value stream in order to benefit our industry partners.”

“As we evaluated the opportunity, we wanted to ensure that there would be limited disruption in the way we currently operate, who we provide our manufacturing services to, and most importantly our employees. By combining the impressive skills and capabilities of Nextremity Solutions with our strong manufacturing skills we will be able to better serve current customers, and firmly believe that all parties will benefit favorably from this acquisition,” says Terry Sites, president of Lakeland Technology.

Rod K. Mayer, president & CEO of Nextremity Solutions adds, “Our board of directors and our executive management team is excited to take this next strategic step forward in optimizing our ability to deliver comprehensive and innovative solutions to the surgeons, patients, and industry partners that we serve.”